Abstract:
Embodiments are related to compositions of matter comprising a food, drug, cosmetic, dietary supplement, or biologic product, said product comprised of a phytochemical fraction recovered from a crude caffeine, said phytochemical fraction having a ratio of polyphenols to caffeine of about 20, 10-30 or 40, or greater than 10. In related embodiments, said phytochemical fraction is a retentate of a filtration process of a water suspension of crude caffeine, and wherein said crude caffeine is a product of a green coffee bean decaffeination process. In other related embodiments, said compositions of matter are useful for facilitating neuroprotection, inhibiting COX-2, or stimulating glucose uptake.
Abstract:
An improved food product comprising a comestible and a crude caffeine complex as a functional additive is provided. The crude caffeine complex includes a blend of caffeine and coffee-based biologically active compounds. The additive demonstrates an ability to stimulate glucose uptake into cells, provide antioxidant benefits, and anti-inflammatory activities. A method of using the crude caffeine complex and incorporating the crude caffeine complex in comestibles is also provided.
Abstract:
The disclosures relates to methods for suppressing beta-amyloid 1-42 levels in the hippocampus of a subject, methods for reducing and/or preventing the formation of amyloid plaques in the hippocampus of a subject, and methods for improving cognitive function and/or memory retention in a subject. The methods include administering an effective amount of crude caffeine to the subject. The crude caffeine is prepared from a coffee decaffeination process and contains a combination of caffeine and coffee-based biologically active compounds. Crude caffeine is therefore believed to slow down the progression of plaque-associated dementia, including Alzheimer's Disease (AD), through an Aβ-dependent mechanism and can be used a therapeutic agent against plaque-associated dementia.